191 related articles for article (PubMed ID: 32051008)
1. Efficacy of imidacloprid 10%/moxidectin 1% spot-on formulation (Advocate®) in the prevention and treatment of feline aelurostrongylosis.
Heuer L; Petry G; Pollmeier M; Schaper R; Deuster K; Schmidt H; Blazejak K; Strube C; Di Cesare A; Traversa D; Schnyder M; McKay-Demeler J; von Samson-Himmelstjerna G; Mangold-Gehring S; Böhm C
Parasit Vectors; 2020 Feb; 13(1):65. PubMed ID: 32051008
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Bravecto
Raue K; Rohdich N; Hauck D; Zschiesche E; Morelli S; Traversa D; Di Cesare A; Roepke RKA; Strube C
Parasit Vectors; 2021 Feb; 14(1):110. PubMed ID: 33593394
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of Bravecto
Raulf MK; Raue K; Rohdich N; Zschiesche E; Raue J; Merhof K; Volk HA; Schnyder M; Morelli S; Traversa D; Roepke RKA; Strube C
Parasit Vectors; 2024 Apr; 17(1):193. PubMed ID: 38658960
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of imidacloprid 10%/moxidectin 1% spot-on formulation in the treatment of feline aelurostrongylosis.
Traversa D; Di Cesare A; Milillo P; Lohr B; Iorio R; Pampurini F; Schaper R; Paoletti B; Heine J
Parasitol Res; 2009 Aug; 105 Suppl 1():S55-62. PubMed ID: 19575226
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of a moxidectin/imidacloprid spot-on formulation (Advocate
Diakou A; Morelli S; Dimzas D; Di Cesare A; Capelli G; Parrinello C; Pollmeier M; Schaper R; Traversa D
Parasit Vectors; 2019 Nov; 12(1):519. PubMed ID: 31685011
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of a novel topical combination of fipronil, (S)-methoprene, eprinomectin and praziquantel against larval and adult stages of the cat lungworm, Aelurostrongylus abstrusus.
Knaus M; Chester ST; Rosentel J; Kühnert A; Rehbein S
Vet Parasitol; 2014 Apr; 202(1-2):64-8. PubMed ID: 24703080
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of a combination of selamectin plus sarolaner for the treatment and prevention of flea infestations and the treatment of ear mites in cats presented as veterinary patients in the United States.
Vatta AF; Myers MR; Rugg JJ; Chapin S; Pullins A; King VL; Rugg D
Vet Parasitol; 2019 Jun; 270 Suppl 1():S3-S11. PubMed ID: 30579753
[TBL] [Abstract][Full Text] [Related]
8. Shedding of feline lungworm larvae and their infectivity to snail intermediate hosts after anthelmintic treatment.
Cavalera MA; Colella V; Napoli E; Arfuso F; Panarese R; Brianti E; Otranto D
Int J Parasitol; 2019 May; 49(6):449-453. PubMed ID: 30904621
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of a spot-on combination containing 10% w/v imidacloprid and 1% w/v moxidectin for the treatment of troglostrongylosis in experimentally infected cats.
Traversa D; Raue K; Ringeisen H; Blazejak K; Bisterfeld K; Di Cesare A; Colombo M; Böhm C; Strube C; Pollmeier M
Parasit Vectors; 2022 Feb; 15(1):66. PubMed ID: 35193656
[TBL] [Abstract][Full Text] [Related]
10. Imidacloprid/moxidectin topical solution for the prevention of heartworm disease and the treatment and control of flea and intestinal nematodes of cats.
Arther RG; Charles S; Ciszewski DK; Davis WL; Settje TS
Vet Parasitol; 2005 Oct; 133(2-3):219-25. PubMed ID: 16198823
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of Emodepside/Praziquantel Spot-on (Profender®) against adult Aelurostrongylus abstrusus Nematodes in Experimentally Infected Cats.
Böhm C; Wolken S; Schnyder M; Basso W; Deplazes P; Di Cesare A; Deuster K; Schaper R
Parasitol Res; 2015 Aug; 114 Suppl 1():S155-64. PubMed ID: 26152416
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of a spot on combination containing imidacloprid 10% and moxidectin 1% (Advocate(®)/Advantage(®) Multi, Bayer Animal Health) against Ancylostoma ceylanicum in cats.
Taweethavonsawat P; Chungpivat S; Watanapongchati S; Traub RJ; Schaper R
Vet Parasitol; 2012 Nov; 190(1-2):289-93. PubMed ID: 22677133
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of the spot-on combination of moxidectin and imidacloprid (Advocate®) in the treatment of ocular thelaziosis by Thelazia callipaeda in naturally infected cats.
Otranto D; Solari Basano F; Pombi M; Capelli G; Nazzari R; Falsone L; Petry G; Pollmeier MG; Lia RP
Parasit Vectors; 2019 Jan; 12(1):25. PubMed ID: 30635002
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of a single topical application of Advantage Multi (= Advocate) Topical Solution (10% imidocloprid + 2.5% moxidectin) in the treatment of dogs experimentally infected with Crenosoma vulpis.
Conboy G; Hare J; Charles S; Settje T; Heine J
Parasitol Res; 2009 Aug; 105 Suppl 1():S49-54. PubMed ID: 19575225
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of Broadline® spot-on against Aelurostrongylus abstrusus and Troglostrongylus brevior lungworms in naturally infected cats from Italy.
Giannelli A; Brianti E; Varcasia A; Colella V; Tamponi C; Di Paola G; Knaus M; Halos L; Beugnet F; Otranto D
Vet Parasitol; 2015 Apr; 209(3-4):273-7. PubMed ID: 25819917
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of imidacloprid 10%/moxidectin 1% spot-on formulation in the treatment of feline infection by Capillaria aerophila.
Traversa D; Di Cesare A; Di Giulio E; Castagna G; Schaper R; Braun G; Lohr B; Pampurini F; Milillo P; Strube K
Parasitol Res; 2012 Oct; 111(4):1793-8. PubMed ID: 22782476
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of a spot-on formulation containing 280 mg/ml fluralaner and 14 mg/ml moxidectin (Bravecto® Plus) in the prevention of cat aelurostrongylosis under field conditions.
Di Cesare A; Morelli S; Rohdich N; Kirkova Z; Capári B; Loehlein W; Wolf O; Zschiesche E; Colombo M; Astuti C; Traversa D
Vet Parasitol; 2024 Apr; 327():110114. PubMed ID: 38286060
[TBL] [Abstract][Full Text] [Related]
18. Safety of imidacloprid plus moxidectin topical solution applied to cats heavily infected with adult heartworms (Dirofilaria immitis).
Arther RG; Atkins C; Ciszewski DK; Davis WL; Ensley SM; Settje TL
Parasitol Res; 2005 Oct; 97 Suppl 1():S70-S75. PubMed ID: 16228278
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the Adulticidal Efficacy of Imidacloprid 10 %/Moxidectin 2.5 % (w/v) Spot-on (Advocate®, Advantage® Multi) against Dirofilaria repens in Experimentally Infected Dogs.
Petry G; Genchi M; Schmidt H; Schaper R; Lawrenz B; Genchi C
Parasitol Res; 2015 Aug; 114 Suppl 1():S131-44. PubMed ID: 26152414
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of emodepside 2.1%/praziquantel 8.6% spot-on formulation in the treatment of feline aelurostrongylosis.
Traversa D; Milillo P; Di Cesare A; Lohr B; Iorio R; Pampurini F; Schaper R; Bartolini R; Heine J
Parasitol Res; 2009 Aug; 105 Suppl 1():S83-9. PubMed ID: 19575229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
